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Bacterial DNA and oligodeoxynucleotides containing
cytosine^phosphate^guanosine sequences and thereby
mimicking prokaryotic DNA, have recently been
shown to exert potent immunostimulatory properties.
As skin normally harbors bacteria, and as the bacterial
content and the levels of bacterial degradation products
increase during skin infection, we analyzed the poten-
tial in£ammatogenic role of bacterial DNA and oligo-
deoxynucleotides in a mouse model of cutaneous
in£ammation. Bacterial DNA from Staphylococcus aureus
was injected intradermally into mice and its in£amma-
togenic properties were compared with synthetic phos-
phodiester and phosphorothioate cytosine^phosphate^
guanosine- or GpC-containing oligodeoxynucleotides.
A peak in£ammatory in¢ltrate in the skin was seen
already 2 d after injection with either bacterial DNA
or the phosphodiester cytosine^phosphate^guanosine-
oligodeoxynucleotides. In contrast, nuclease-resistant
phosphorothioate cytosine^phosphate^guanosine-in-
duced dermatitis peaked 7 d after intradermal injection.
The in£ammatory in¢ltrates consisted mainly of
macrophages, and depletion of this cell population re-
sulted in a signi¢cant (p¼ 0.0001) decrease in the sever-
ity of in£ammation, which suggests that macrophages
play a central part in in£ammatory responses in the
skin following exposure to cytosine^phosphate^guano-
sine-containing oligodeoxynucleotides. A signi¢cant
decrease in local in£ammatory in¢ltrate was also seen
in mice with de¢ciencies in neutrophil or lymphocyte
populations, which indicates that these cell populations
may also be involved in mediating in£ammatory sig-
nals after the injection of immunostimulatory DNA se-
quences. In summary, our results suggest that bacterial
DNA is an important virulence determinant and in-
£ammatory stimulus during skin infections. Key words:
bacterial DNA/mice/skin/synthetic oligodeoxynucleotides. J
Invest Dermatol 121:294 ^299, 2003
B
acterial DNA is known to have stimulatory e¡ects
(Tokunaga et al, 1984;Yamamoto et al, 1992) on several
immune cell populations, in both humans and mice.
This e¡ect has been shown to be largely dependent
on cytosine^phosphate^guanosine (CpG) sequences
(reviewed in Krieg, 2002) that are unmethylated at cytosine resi-
dues. This is in contrast to eukaryotic nuclear DNA, which is ty-
pically methylated at cytosine residues and has signi¢cantly fewer
CpG dinucleotides compared with the bacterial genome (Bird,
1987). These di¡erences in structure and content render eukaryo-
tic nuclear DNA nonstimulatory. Synthetic ogliodeoxynucleo-
tides have been used to study the in vitro e¡ects of DNA on
di¡erent immune cell populations, and modi¢cations such as the
incorporation of nuclease-resistant backbone structures, have
been shown to amplify dramatically the immunostimulatory
properties (Krieg et al, 1995). Inversion of the dinucleotide CpG
to GpC, or alterations to the £anking sequences abrogate the im-
munostimulatory e¡ect. Phosphorothioate ogliodeoxynucleotides
are more resistant to degradation by nucleases compared with
phosphodiester-containing ogliodeoxynucleotides, and are
powerful activators of macrophages, dendritic cells, neutrophils,
and B cells. Some researchers suggest that bacterial DNA should
be regarded as one of the pathogen-associated molecular patterns,
together with lipopolysaccharide and lipoteichoic acid (reviewed
by Hacker et al, 2002). Immunostimulatory ogliodeoxynucleo-
tides are optimally 20 nucleotides in length and the £anking re-
gions are also of importance for the stimulatory e¡ects. Speci¢c
nucleotide sequences have been shown to have optimal immu-
nostimulatory activities for di¡erent species (Van Uden and Raz,
2000). For example, the optimal sequence for the activation of
murine cells is GACGTT, and the optimal sequence for the acti-
vation of human cells is GTCGTT. Ogliodeoxynucleotides acti-
vation of immune cells can be used for its bene¢cial e¡ects, e.g.,
as adjuvants in vaccination; however, adverse in£ammatory e¡ects
that follow the administration of ogliodeoxynucleotides com-
prise both local and systemic reactions, including arthritis (Deng
et al, 1999), meningitis (Deng et al, 2001), and life-threatening
symptoms of septic shock (Sparwasser et al, 1997). The aim of this
study was to assess the in£ammatogenic potential of bacterial
DNA and synthetic ogliodeoxynucleotides in the skin. The
elucidation of DNA-induced pathways of in£ammation is
particularly relevant to dermatology since (1) bacterial infections
frequently occur in the skin, and (2) synthetic oligonucleotides
are frequently administered intracutaneously or subcutaneously,
as part of a vaccination regimen.
MATERIALS ANDMETHODS
Mice Female, 8 wk old NMRI mice and female 7 to 8 wk old BALB/C
mice were purchased from B&K Universal (Sollentuna, Sweden). Female
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SCID mice and sex-matched congeneic CB17 control mice were purchased
from M&B (Bomholtvej, Denmark). The mice were housed at the animal
facility of the Department of Rheumatology and In£ammation Research,
University of G˛teborg and maintained under standard conditions of
temperature and light, and fed laboratory chow and water ad libitum.
Oligonucleotides The nuclease-resistant, phosphorothioate^backbone
ogliodeoxynucleotides and the phosphodiester-backbone ogliodeoxy-
nucleotides that were used in this study are listed in Table I. All of the
ogliodeoxynucleotides were synthesized by Scandinavian Gene Synthesis
AB (K˛ping, Sweden), and shown to contain less than 5 fg of endotoxin
per mg DNA, as assessed by the Limulus amoebocyte lysate assay. Genomic
DNA was puri¢ed from Staphylococcus aureus strain LS-1 as described
previously (Deng et al, 1999) and resuspended in phosphate-bu¡ered saline
(PBS). The DNA sample originating from S. aureus was shown to contain
0.04 pg of endotoxin per mg DNA (Limulus amoebocyte lysate assay,
Charles River, Charleston). Nuclear DNA was extracted from nuclei
isolated from NMRI mouse livers essentially as described byWang (1967).
Ten micrograms of the respective ogliodeoxynucleotide were injected
intradermally on the shaved back of the mice. The oligonucleotides were
diluted in PBS, and inoculated in a volume of 50 mL.
Histopathologic examination After routine procedures, tissue sections
from skin samples corresponding to the injection sites were cut and stained
with hematoxylin and eosin. All slides were coded and assessed in a
blinded manner. The specimens were evaluated with regard to the extent
of the in£ammation and judged on an arbitrary scale, from grade 0 (no
signs of in£ammation), grade 1 (mild di¡use or focal in£ammation in a
single area), to grade 2 (moderate di¡use or focal in£ammation), and
grade 3 (heavy di¡use and focal in£ammation). Examples of typical grade
0, 1, 2, and 3 reactions are presented in Fig 1.
Skin samples were also analyzed regarding the occurrence of
CD11bþ cells encompassing macrophages and neutrophils (macrophages
expressing a single rounded nucleus and neutrophils displaying
multilobular nucleus) and CD3-expressing T cells. Brie£y, skin samples
were frozen in isopentane prechilled with liquid nitrogen, and kept













Figure1. Grading of severity of cutaneous in£ammation following injection with DNA. Representative photomicrographs of skin biopsies
(stained with hematoxylin/eosin) represent di¡erent degrees of in£ammatory in¢ltrates. (a) no in£ammation (grade 0); (b) mild di¡use or focal in£amma-
tion in a single area (grade 1); (c) moderate di¡use or focal in£ammation (grade 2); and (d) heavy di¡use and focal in£ammation in an extended pattern
(grade 3). In (a) 10 mg of phosphorothioate-GpCwas injected, in (b^d) 10 mg of phosphorothioate-CpG was injected. All samples were collected at day 7 after
injection.
IMMUNOSTIMULATORY EFFECTS OF BACTERIAL DNA IN SKIN 295VOL. 121, NO. 2 AUGUST 2003
at 701C until cryosectioned. All of the sections were ¢xed in cold acetone
for 5 min and washed in PBS. The sections were incubated overnight in a
humid atmosphere at þ 41C with unlabeled rat anti-CD11b (Mac-1;
M1/70) (Springer et al, 1979) or rat anti-CD3 (clone
17A2 PharMingen, San Diego, California) monoclonal antibodies
(MoAb), which were diluted in PBS containing 1% bovine serum
albumin. After several washes, endogenous peroxidase was depleted
by treatment with 0.3% H2O2 for 5min biotin-labeled rabbit anti-rat
immunoglobulin (Vector Laboratories, Burlingame, California) diluted
in PBS/bovine serum albumin were used as secondary anti-bodies.
The binding of biotin-labeled secondary antibodies was detected by
stepwise incubation with streptavidin^biotin complex/horseradish
peroxidase (DAKO, Glostrup, Denmark) and 3-amino-9-ethyl-carbazole
containing H2O2. All sections were counterstained with Meyer’s
hematoxylin.
Monocyte/macrophage depletion Etoposide (Bristol-Myers Squibb
AB, Bromma, Sweden) is a cytotoxic drug that is known to deplete
selectively the monocyte/macrophage populations in rabbits and mice
(Van’t Wout et al, 1989). Etoposide acts by inhibiting the function of DNA
topoisomerase II, and thus interrupts the late S/G2 phase of the cell cycle
(Smith et al, 1994). Etoposide was diluted 1:10 in PBS (0.13 M NaCl,
10 mM sodium phosphate (pH 7.4)) from a stock solution of 20 mg per
mL. A volume of 120 mL, which corresponded to 12.5 mg per kg body
weight of etoposide, was injected subcutaneously (s.c.) in BALB/C mice
on 2 consecutive days before, and on 5 consecutive days after, intradermal
injection of the phosphorothioate ogliodeoxynucleotide. The dose of
etoposide was chosen according to that established in earlier studies
(Calame et al, 1994). Fluorescence-activated cell sorter analysis of
peripheral blood was performed to assess the e¡ect of macrophage
depletion, as previously described in detail (Verdrengh and Tarkowski,
2000), and showed that etoposide depleted the monocyte population by
80%. Control BALB/C mice received the same volume of PBS
intraperitoneally (n¼ 5) or subcutaneously (n¼ 5).
Neutrophil depletion MoAb RB6-8C5 is a rat immunoglobulin G2b
(IgG2b) antibody that selectively binds to and depletes mature mouse
neutrophils and eosinophils in BALB/C but not NMRI strain of mice.
Hybridoma cells secreting RB6-8C5 were a kind gift from R. Co¡man
(DNAX Research Institute, Palo Alto, California). The hybridoma cells
were expanded in Iscove’s medium (Gibco, Paisley, UK) supplemented
with 5% heat-inactivated fetal bovine serum (Seralab, Crawley Down,
UK), 50 mg gentamicin per mL, 2 mM L-glutamine, and 510^5 M
b-mercaptoethanol. The cells were grown to maximum density and the
immunoglobulins were precipitated with 50% saturated ammonium
sulfate, dialyzed against PBS, and ¢lter sterilized. The concentrations of
immunoglobulins were determined by the radial immunodi¡usion
method (Mancini et al, 1965). As a control, monoclonal immunoglobulin-
class-matched anti-ovalbumin antibodies (anti-OVA MoAb) were used
(kindly provided by Dr Telemo, Department of Rheumatology and
In£ammation Research, University of G˛teborg, Sweden).
Analysis of peripheral blood by £uorescence-activated cell sorter has
previously shown depletion of the granulocyte population by more than
90% within 48 h (Deng et al, 2000; Molne et al, 2000). BALB/C mice
were injected intraperitoneally with one mg of either the MoAb RB6-
8C5 or the class-matched anti-OVA MoAb 2 h before, and 2 and 5 d after
intracutaneous injection of the CpG-ogliodeoxynucleotide.
Interleukin (IL)-6 analysis Serum IL-6 levels was assessed to measure
a possible systemic e¡ect of the oligonucleotide administered. The cell line
B13.29, which is dependent on IL-6 for growth, has been described
previously (Lansdorp et al, 1986; Aarden et al, 1987; Helle et al, 1988). For
IL-6 determinations, the more sensitive subclone B9 was used. B9 cells
were harvested from tissue culture £asks, seeded on to microtiter plates
(Nunc, Roskilde, Denmark) at a concentration of 5000 cells per well, and
cultured in Iscove’s medium supplemented with 5105 M 2-
mercaptoethanol, 10% fetal bovine serum gentamycin (50 mg per mL),
and L-glutamine. The serum samples were added for 68 h and
[3H]thymidine was added 4 h prior to harvesting. Each sample was tested
for IL-6 in a series of 2-fold dilutions and compared with a recombinant
IL-6 standard. B9 cells do not react with recombinant cytokines, such as
IL-1a, IL-1b, IL-2, IL-3, IL-5, granulocyte-macrophage colony-stimulating
factor, tumor necrosis factor-a, and interferon-g and have only weak
reactivity with IL-4 (Helle et al, 1988).
Experimental protocol NMRI mice were injected intradermally with
either phosphorothioate CpG-ogliodeoxynucleotide or GpC-ogliodeoxy-
nucleotide and serum samples were taken for analysis of IL-6 levels at
days 0, 2, 7, and 21. Skin samples for histopathologic analysis of the size
and density of the in£ammatory in¢ltrate were obtained at days 2, 7, and
21. NMRI mice were also injected with phosphodiester CpG-ogliodeoxy-
nucleotide or GpC-ogliodeoxynucleotide as well as DNA from S. aureus
LS-1 strain. Skin samples were obtained for histopathologic analysis on
days 2 and 7 postinoculation. SCID mice and their controls (CB17) were
injected intradermally with phosphorothioate CpG-ogliodeoxynucleotide
and skin samples for histopathologic analysis were obtained at day 7.
The BALB/C mice were injected with phosphorothioate CpG-
ogliodeoxynucleotide and with etoposide, RB6-8C5, control MoAb, or
PBS, respectively. Skin samples for histopathologic analysis were obtained
7 d after injection of the ogliodeoxynucleotide.
Statistical analysis The di¡erences between mean values were tested for
statistical signi¢cance using the nonparametric Mann^Whitney U test.
pr0.05 was considered to be statistically signi¢cant.
Ethics This study was approved by the local ethics committee for animal
use (registration number 175^2000) at Goº teborg University.
RESULTS
Nuclease-resistant, phosphorothioate-modi¢ed CpG oligonu-
cleotide (oligonucleotide 1600) induced in£ammation in the skin
of NMRI mice at doses of 50 mg as well as 10 mg. As no major
di¡erences were observed in either the size or density of the in-
£ammatory in¢ltrate, a dose of 10 mg of oligonucleotide was used
consistently throughout this study. An in£ammatory in¢ltrate
equal to grade 2 or 3 frequently included all layers of the skin
and often engaged not only subcutaneous fat and dermis, but also
the super¢cial muscle. The in£ammatory in¢ltrate consisted
mainly of macrophages, whereas neutrophils were less frequent.
Lymphocytes occurred sparsely in all the skin biopsies. These
¢ndings were con¢rmed with immunohistochemistry.
In£ammatogenic properties of phosphodiester^ogliodeoxy-
nucleotide and phosphorothioate-ogliodeoxynucleotide in
murine skin Nuclease-sensitive, phosphodiester CpG-oligo-
nucleotide (oligonucleotide 0899) triggered in£ammatory
changes in NMRI mice with peak values 2 d after injection and
almost complete resolution 7 d after injection (Fig 2). The
Figure 2. In£ammatory responses triggered by bacterial DNA and
phosphodiester oligonucleotides. Nuclease-sensitive bacterial DNA
from S. aureus LS-1 triggers heavy in£ammatory changes in skin within 2
d following injection, whereas the GpC-ogliodeoxynucleotide is inert. On
day 7 the in£ammatory responses have resolved partially, with absence of
in£ammation in mice injected with PBS or GpC-ogliodeoxynucleotide,
but with still noticeable in£ammation in mice injected with bacterial
DNA and CpG-ogliodeoxynucleotide (n¼ 9^10 in all groups) (nnpo0.01;
npo0.05).
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injection of bacterial DNA (S. aureus LS-1) in NMRI mice
displayed the same pattern of in£ammation, with peak values 2
d after injection (Fig 2). Furthermore, the in£ammation was
more pronounced in the bacterial-DNA injection group. In
contrast, injection of phosphodiester GpC-oligonucleotide
(oligonucleotide, 1800) did not trigger in£ammation (Fig 2).
Methylated phosphodiester CpG-ogliodeoxynucleotide (oglio-
deoxynucleotide 2798) did not induce any in£ammation in
seven of nine NMRI mice, and slight (grade 1) in£ammation in
two of nine mice 7 d after injection. Nuclease-resistant, phospho-
rothioate-modi¢ed CpG-oligonucleotide induced in£ammatory
changes in NMRI mice that peaked at day 7, with almost total
resolution at day 21 (Fig 3). The few remaining in£ammatory
cells present on day 21 were mostly of monocyte/macrophage
origin.
For the control purpose, we have also assessed the impact of
homologous DNA (mouse liver DNA) on the induction of skin
in£ammation. Our results show clearly that NMRI mice injected
intracutaneously with 10 mg of highly puri¢ed nuclear mouse
liver DNA will not rise any in£ammatory response (day 2: one
of 10 mice displayed grade 1 in£ammation; day 7: none of 10
mice displayed in£ammation).
E¡ects of depletion of immune cell populations on
oligonucleotide-induced skin in£ammation The presence
of macrophages has been shown to be mandatory for the
development of arthritis following intra-articular injection of
CpG-oligonucleotide, whereas neutrophils, natural killer cells, T
cells, and B cells played minor parts in this type of in£ammation
(Deng et al, 2000).We investigated whether this pattern was also
valid for DNA-triggered in£ammation of the skin. BALB/C
mice were injected intradermally with 10 mg of CpG-
ogliodeoxynucleotide (ogliodeoxynucleotide 1600) and admini-
stered with (1) the macrophage-depleting drug etoposide
(n¼10), or (2) the anti-granulocytic antibody RB6-8C5
(n¼19), or (3) PBS or immunoglobulin class-matched IgG anti-
bodies speci¢c for ovalbumin (n¼ 21). SCID mice (n¼ 9), which
lack both T and B cells and their congeneic (CB17) controls
(n¼ 9) were also injected with 10 mg of CpG-oglio-
deoxynucleotide (ogliodeoxynucleotide 1600). All of the mice
were killed 7 d after injection and skin samples were obtained
for histopathologic examination and grading (see Materials and
Methods section). Depletion of monocytes/macrophages with
etoposide resulted in a signi¢cant reduction in the severity of
in£ammation in the skin (p¼ 0.0001). A statistically signi¢cant
(p¼ 0.0001) decrease in the in£ammatory in¢ltrates was seen
also in mice that were treated with anti-granulocytic antibodies
(Fig 4). Also, signi¢cant di¡erences of low degree (po0.05)
were seen in the severity of the in£ammatory in¢ltrate in SCID
mice compared with controls (Fig 4).
Serum IL-6 levels Serum levels of IL-6 have been shown
to increase transiently after intra-articular injection of CpG-
ogliodeoxynucleotide (Deng and Tarkowski, 2000). Intra-
cutaneous injection of DNA led to a slight, but not statistically
signi¢cant, increase in serum levels of IL-6 2 d after intradermal
injection of 10 mg of phosphorothioate CpG-ogliodeoxy-
nucleotide (58710 pg per mL on day 0 vs 163752 pg per mL
on day 2 (mean7SEM); p¼ 0.06). There were no statistically
signi¢cant di¡erences in serum IL-6 levels in these groups
compared with groups of mice injected with the same dose of
GpC-ogliodeoxynucleotide (data not shown).
DISCUSSION
The skin is frequently exposed to both bacterial DNA, e.g., dur-
ing cutaneous infections such as erysipelas and impetigo, and to
synthetic phosphorothioate oligonucleotide, as in adjuvants and
various vaccination regimens. We have previously shown that
Figure 3. Phosphorothioate CpG-ogliodeoxynucleotide but not
GpC-oligonucleotide triggers cutaneous in£ammation. Signi¢cant
local skin in£ammation is evident following intradermal injection of
10 mg of phosphorothioate CpG-ogliodeoxynucleotide compared with
10 mg of phosphorothioate GpC-ogliodeoxynucleotide. Pooled data
from three di¡erent experiments are shown (n¼ 8^10, day 2; n¼18^19,
day 7; and n¼ 7^9, day 21) (npo0.05; nnnpo0.001; n.s., not statistically
signi¢cant).
Figure 4. Depletion of immune cells results in a signi¢cant decrease
in the severity of skin in£ammation induced by phosphorothioate
CpG-ogliodeoxynucleotide. BALB/C mice and CB-17 SCID mice as
well as their controls (CB17) were injected intradermally with 10 mg of
phosphorothioate CpG-ogliodeoxynucleotide. Depletion of monocytes/
macrophages (n¼10) by etoposide as well as depletion of neutrophils
(n¼19) by anti-neutrophilic antibody RB6-8C5 resulted in a signi¢cant
decrease of the severity of the in£ammation (nnnpo0.0001), compared with
BALB/C mice injected with CpG and relevant control (OVA MoAb; n¼10
or PBS; n¼11). Results from both control groups are pooled, as no di¡er-
ences were seen between the groups. Also, the ogliodeoxynucleotide-in-
duced in£ammatory in¢ltrates in SCID mice (n¼ 9) and their controls
(CB17) (n¼ 9) were signi¢cantly di¡erent after injection with the same
dose (10 mg) of CpG-ogliodeoxynucleotide (npo0.05). All samples are col-
lected at day 7 following injection with CpG-ogliodeoxynucleotide.
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bacterial DNA, in contrast to eukaryotic nuclear DNA, exerts in-
£ammatory e¡ects in joints (Deng et al, 1999) and in the central
nervous system (Deng et al, 2001). Similar ¢ndings have also been
reported by others (Schluesener et al, 2001; Takeshita et al, 2001;
Zeuner et al, 2002). The immunostimulatory e¡ects of bacterial-
like CpG oligonucleotides require DNA uptake and endosomal
acidi¢cation (reviewed in Krieg, 1999), and are mediated through
Toll-like receptor 9, which recognizes a speci¢c pattern in the
bacterial DNA (Hemmi et al, 2000). As the skin is commonly
the site of bacterial infections and almost exclusively the site of
vaccination procedures, we felt that the question related to in-
£ammatogenicity of prokaryotic DNA sequences in this com-
partment should be addressed. Our results indicate both
similarities and di¡erences between bacterial DNA in£ammato-
genicity in the skin as compared with the joints.
In accordance with previous results, (Deng et al, 1999) mono-
cytes/macrophages played a central part in mediating skin in£am-
mation following intracutaneous injection of bacterial DNA.
Indeed, both histologic stainings and immunohistochemistry of
skin samples showed a plethora of macrophages that had in¢l-
trated all layers of the skin. In addition, pretreatment of mice
with a topoisomerase II inhibitor (etoposide), which leads to se-
lective apoptosis of monocytic cells, resulted in signi¢cant down-
regulation of the in£ammatory response of skin to DNA. Thus,
this cell population and its soluble products (e.g., cytokines, che-
mokines, nitric oxide) are crucial to the observed in£ammatory
response to DNA. This ¢nding is corroborated by the recent
study of von Stebut et al (2002), where stimulation of skin-
derived macrophages with CpG-ogliodeoxynucleotide resulted
in induction of IL-12, interferon-g, and nitric oxide resulting in
killing of Leishmania parasites. Interestingly, and in contrast to
previous ¢ndings in DNA-injected joints, neutrophils also parti-
cipated in DNA-triggered skin in£ammation. Indeed, depletion
of this cell population with a speci¢c MoAb led to a signi¢cant
downregulation of the in£ammatory responses in skin. It should
be pointed out that in order to assess the signi¢cance of neutro-
phils with regard to bacterial DNA-triggered skin in£ammation
we needed to use another strain of mice (BALB/C), known to be
sensitive to the depletion procedure. Recent work from our la-
boratory (Bylund et al, 2002) showed that phosphorothioate
CpG-oligonucleotide activation of neutrophils led to respiratory
burst and degranulation of both speci¢c and gelatinase granules.
In contrast to the active roles of monocytes/macrophages and
neutrophils in bacterial DNA-triggered skin in£ammation, it is
clear that the acquired immune system does not as vividly partici-
pate in this process. SCID mice, which lack functional T/B lym-
phocytes, showed somewhat less severe in£ammation compared
with those of the congeneic CB17 strain. Most probably, this ¢nd-
ing is due to the lack of B cells, known to be activated by bacterial
DNA (Yi et al, 1998). In this study, we showed that both phospho-
diester-backbone DNA and phosphorothioate-backbone DNA
were able to trigger skin in£ammation; however, the phosphodie-
ster-oligonucleotide, as well as staphylococcal DNA-triggered in-
£ammatory responses were less durable compared with those
induced by synthetically modi¢ed phosphorothioate-backbone
oligonucleotides.
What is the biological signi¢cance of our ¢ndings? It has been
suggested that local intradermal injection of CpG ogliodeoxynu-
cleotide triggers an early host response to a simulated bacterial
invasion, as indicated by increased migration of Langerhans cells
from the epidermis (Ban et al, 2000). Di¡erent routes of adminis-
tration of CpG-ogliodeoxynucleotide may lead to di¡erential ac-
tivation patterns of immune cells, e.g., predominantly polymor-
phonuclear granulocytes in the case of in£ammation in the lower
respiratory tract (Schwartz et al, 1997). Systemic, rather than local
administration of CpG-ogliodeoxynucleotide, led to down-
modulation of in£ammation in an experimental model of asthma
(Kline et al, 1998). The potential of immunostimulatory DNA se-
quences to trigger a T helper 1-polarized response is well docu-
mented and might be bene¢cial in chronic skin diseases that
have T helper 2-type immune reactivity, such as pemphigus,
pemphigoid, and cutaneous lupus erythematosus. Altogether
our results indicate that both bacterial DNA and synthetic
ogliodeoxynucleotide trigger local skin in£ammation. Limited,
local in£ammation of this type might be advantageous for
the host in allowing it to mobilize an e⁄cient protective re-
sponse. Under certain circumstances, however, this might induce
or aggravate chronic skin in£ammatory diseases, such as eczema
and psoriasis.
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